Clinical Trials
4
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant
Phase 1
Terminated
- Conditions
- AnemiaEnd Stage Renal Disease
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- Medgenics Medical Israel Ltd.
- Target Recruit Count
- 4
- Registration Number
- NCT01555515
Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients
Phase 1
Terminated
- Conditions
- Hepatitis C
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- Medgenics Medical Israel Ltd.
- Target Recruit Count
- 3
- Registration Number
- NCT01433133
Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump
Phase 1
Withdrawn
- Conditions
- Hepatitis C
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Medgenics Medical Israel Ltd.
- Registration Number
- NCT01430000
- Locations
- 🇮🇱
Prof. Eithan Galun Gene Therapy Institute, Hadassah Medical Center Ein Kerem, Jerusalem, Israel, Jerusalem, Israel
Safety and Efficacy of Sustained Erythropoietin Therapy
Phase 1
Completed
- Conditions
- Anemia
- First Posted Date
- 2007-10-11
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Medgenics Medical Israel Ltd.
- Target Recruit Count
- 19
- Registration Number
- NCT00542568
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
🇮🇱Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
News
No news found